Sign in →

Test ID STLPC St. Louis Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid

Useful For

Aiding the diagnosis of St. Louis encephalitis using spinal fluid specimens

Method Name

Only orderable as part of a profile. For more information see ABOPC / Arbovirus Antibody Panel, IgG and IgM, Spinal Fluid.

 

Immunofluorescence Assay (IFA)

Reporting Name

St. Louis Enceph Ab Panel, CSF

Specimen Type

CSF


Ordering Guidance


 



Specimen Required


Only orderable as part of a profile. For more information see ABOPC / Arbovirus Antibody Panel, IgG and IgM, Spinal Fluid.

 

Container/Tube: Sterile vial

Preferred: Vial number 1

Acceptable: Any vial

Specimen Volume: 0.7 mL


Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time
CSF Refrigerated (preferred) 14 days
  Frozen  14 days

Reject Due To

Gross hemolysis OK
Gross lipemia OK

Clinical Information

Since 1933, outbreaks of St. Louis encephalitis (SLE) have involved the western United States, Texas, the Ohio-Mississippi Valley, and Florida. The vector of transmission is the mosquito. Peak incidence occurs in summer and early autumn. Disease onset is characterized by generalized malaise, fever, chills, headache, drowsiness, nausea, and sore throat or cough followed in 1 to 4 days by meningeal and neurologic signs. The severity of illness increases with advancing age; persons over 60 years have the highest frequency of encephalitis. Symptoms of irritability, sleeplessness, depression, memory loss, and headaches can last up to 3 years.

 

Infections with arboviruses, including SLE, can occur at any age. The age distribution depends on the degree of exposure to the particular transmitting arthropod relating to age, sex, and occupational, vocational, and recreational habits of the individuals. Once humans have been infected, the severity of the host response may be influenced by age. SLE tends to produce the most severe clinical infections in older persons.

Reference Values

Only orderable as part of a profile. For more information see ABOPC / Arbovirus Antibody Panel, IgG and IgM, Spinal Fluid.

 

IgG: <1:1

IgM: <1:1

Reference values apply to all ages.

Interpretation

Detection of organism-specific antibodies in the spinal fluid (CSF) may suggest central nervous system (CNS) infection. However, these results are unable to distinguish between intrathecal antibodies and serum antibodies introduced into the CSF at the time of lumbar puncture or from a breakdown in the blood-brain barrier. The results should be interpreted with other laboratory and clinical data prior to a diagnosis of CNS infection.

Cautions

All results must be correlated with clinical history and other data available to the attending healthcare professional.

 

False-positive results may be caused by breakdown of the blood-brain barrier or by the introduction of blood into the spinal fluid at collection.

 

Since cross-reactivity with dengue fever virus does occur with St. Louis encephalitis antigens, and, therefore, cannot be differentiated further, the specific virus responsible for positive results may be deduced by the travel history of the patient, along with available medical and epidemiological data, unless the virus can be isolated.

Clinical Reference

1. Diaz A, Coffey LL, Burkett-Cadena N, et al. Reemergence of St. Louis Encephalitis Virus in the Americas. Emerg Infect Dis. 2018;24(12):2150-2157. doi:10.3201/eid2412.180372

2. Piantadosi A, Kanjilal S. Diagnostic approach for arboviral infections in the United States. J Clin Microbiol. 2020;58(12):e01926-19. doi:10.1128/JCM.01926-19

Method Description

The indirect immunofluorescent antibody (IFA) assay is a 2-stage “sandwich" procedure. In the first stage, the patient spinal fluid (CSF) is diluted in Pretreatment Diluent for IgM and phosphate buffered saline (PBS) for IgG, added to appropriate slide wells in contact with the substrate, and incubated. Following incubation, the slide is washed in PBS which removes unbound CSF antibodies. In the second stage, each antigen well is overlaid with fluorescein-labeled antibody to IgM and IgG. The slide is incubated allowing antigen-antibody complexes to react with the fluorescein-labeled anti-IgM and anti-IgG. After the slide is washed, dried, and mounted, it is examined using fluorescence microscopy. Positive reactions appear as cells exhibiting bright apple-green cytoplasmic fluorescence against a background of red negative control cells. Semi-quantitative endpoint titers are obtained by testing serial dilutions of positive specimens.(Package inserts: Arbovirus IFA IgM and Arbovirus IFA IgG Instructions for Use. Focus Diagnostics; Rev. 03, 02/17/2023)

Day(s) Performed

May through October: Monday through Friday

November through April: Monday, Wednesday, Friday

Report Available

Same day/1 day to 4 days

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

86653 x 2

NY State Approved

No

Testing Algorithm

For more information see Mosquito-borne Disease Laboratory Testing.